Communications / 04 March 2024
We take a deep dive into the world of serious and unexpected adverse events, termed 'black swan' events, and their profound impact on drug safety, healthcare, and patient care.
Serious and unexpected adverse drug reactions – the ‘black swans’ of pharmacovigilance – can place enormous strain on safety monitoring systems. Drawing examples from the COVID-19 pandemic, François Montastruc from Toulouse University Hospital explains how we can get better at dealing with the unexpected.
Subscribe by visiting the Drug Safety Matters website or listen to the podcast here:
Uppsala Reports editor
@UMCGlobalSafety
Ronald Meyboom, pioneering pharmacovigilance expert who helped establish drug safety monitoring in the Netherlands, died 27 April. He was 79.
11 June 2025
The theme of this year’s conference is inspired by Cairo’s rich cultural and scientific history and commitment to advancing drug safety and regulatory science.
19 March 2025
Public health is at risk now more than ever; with AI it has never been easier to spread mis- and disinformation on health. How do we work smarter to address this threat?
17 June 2025
